Get a clear overview of all current promotions and deals from our suppliers.
Can’t find a product in our catalog, or need a fully custom solution? We’ve got you covered.
Looking for specific products, alternatives, documentation or any other assistance? We’re here to help.
Connect with us in person, and let us connect you to the right products and suppliers for your research.
BLD Pharm offers a comprehensive portfolio of targeted protein degraders, including PROTACs, molecular glues, and building blocks (linkers & E3 ligase ligands), for chemical biology and oncology research.
In this article, MedChem Express reviews the evolution and pipeline of personalized cancer vaccines, highlighting neoantigen sources, screening technologies, and key translational challenges.
With complete biological definition and ensured reproducibility, recombinant antibodies from Absolute Antibody, a Vector Laboratories company, power researchers to study areas like neuroscience, infectious disease, and immunotherapy with confidence.
antibodies.com offers over 1.450 biosimilar antibodies. These high-purity, recombinant tools provide a cost-effective, reliable solution for your drug discovery and pre-clinical research.
Cloud-Clone helps decode the MAPK/ERK signaling pathway across cancer, autoimmune, cardiovascular and neurodegenerative diseases and regeneration with targeted detection reagents.
Bio X Cell now offers high-quality bispecific antibodies and custom engineering services to help you dissect immune pathways and translate cutting-edge bispecific concepts into in vivo research.
Biosynth supplies Poly I:C, a potent TLR3 agonist used as a vaccine adjuvant and in cancer research. Discover Biosynth’s solutions for immunotherapy and vaccine development.
Vazyme delivers no-wash HTS assay kits that cut steps and improve batch-to-batch consistency for small-molecule screening across research and pharma teams.
Absolute Antibody: Tumors develop from oncogene activation and tumor suppressors inactivation. Understanding and targeting these opposing forces is central to cancer biology, and antibodies are vital tools in this research.
Not sure whether to use ELISA or ELISpot? This Mabtech guide breaks down the differences to help you choose the assay best suited for your project.
Cloud-Clone offers a comprehensive product portfolio for exosome research, encompassing core products such as recombinant proteins, antibodies, and detection kits to meet the needs of the entire exosome research process.
Santa Cruz Biotechnology’s Bcl-2 (C-2) antibody is one of the most cited tools for apoptosis research—now available in the BeNeLux via Bio-Connect.
Santa Cruz Biotechnology launches advanced VE-cadherin antibodies to empower vascular biology research in the BeNeLux—available now via Bio-Connect.
Bio-Connect is proud to announce that we supply the innovative research-grade biosimilar antibodies from Absolute Antibody (a Vector Labs company) in the Benelux region.
Bio X Cell’s InVivoMAb anti-mouse TREM2 antibody advances research on myeloid cells, neurodegeneration, and cancer. Learn how this tool supports studies in neurological disorders and oncology.
DNA Diagnostic: Leukemia diagnostics with HemaVision® qPCR test kits are designed for professionals to diagnose Leukemia at its earliest stages, allowing timely and targeted treatment strategies.
Superior bioactivity, low endotoxin levels, high purity, excellent lot-to-lot consistency. Unlock New Possibilities with 12,000+ High-Quality Recombinant Proteins from MedChemExpress.
We now offer the new MSVA-741R recombinant rabbit monoclonal MTAP antibody from MS Validated Antibodies — the most extensively characterized antibody for MTAP detection in cancer research.
MCE provides a wide range of immune checkpoint eukaryotic recombinant proteins, offering high-quality raw materials and tools for immune checkpoint research.
Three newly launched PCR panels from AmoyDx are now available through our distribution network, offering laboratories advanced solutions to enhance the efficiency and scope of molecular testing in oncology.
Research shows the tumor microenvironment’s key role in therapy resistance. RayBiotech’s platforms profile 8000+ proteins, aiding in mapping tumor-immune interactions, identifying biomarkers, and uncovering drug resistance.
AmoyDx® Super-ARMS ESR1 PCR Kit is a highly sensitive real-time PCR assay for detecting ESR1 mutations from plasma cfDNA (liquid biopsy).
Sino Biological: Tumor necrosis factors (TNFs) and their receptors (TNFRs) are key immune regulators. Dysregulation of TNFs/TNFRs is linked to cancer progression, making them critical targets for immunotherapy and drug development.
PTM BIO, the original supplier of lysine lactylation antibodies, has been instrumental in advancing research in cancer, neurodegeneration, and cardiovascular disease.
Revolutionizing the detection of ESR1 mutations, the ZeptoMetrix ESR1 Control Kit ensures precise and reliable results, setting a new standard in laboratory diagnostics.
Assay Genie: Immunometabolism is a growing, multi-disciplinary field of research aiming at deciphering the dynamic cellular and molecular mechanisms that interweave metabolic and immunological processes together.
Absolute Antibody: DNA and RNA are the heart of biological research. Recombinant engineered antibodies against DNA and RNA molecules and structures can unlock experimental opportunities in a variety of research areas.
The LIVE-Step™ Cell Assay System from BPS Bioscience is designed for high-throughput, homogeneous, sensitive luminescence quantification of metabolically active, viable mammalian cells.
MolBoolean™, an in situ proximity technology by Atlas Antibodies, introduces a new approach to protein interaction analysis, offering an alternative to proximity ligation assay (PLA) and expanding research possibilities.
TargetMol: Discover how inhibitory antibodies advance targeted therapies. Learn about monoclonal antibodies, their classifications, functions, and applications in biomedical research and drug development.
We gladly support you by keeping you updated on our latest products and developments